Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Medicine finds itself on the brink of an artificial intelligence (AI) revolution, promising to transform what it means to be human and thus what it means to encounter humans with serious illness. The character of such transformation in pain management remains yet to be determined, leaving open to what extent AI might exacerbate or resolve challenges confronting pain management. In this article, I ...
Hepatocellular carcinoma (HCC) ranks sixth in incidence and third in mortality worldwide, underscoring its public health burden. Ablation therapy is one of the curative treatments for early-stage HCC. With recent advances in systemic therapy, combining ablation with other modalities has demonstrated improved outcomes and has extended applicability to selected patients with intermediate and advance...
OBJECTIVES: Lung cancer is the leading cause of cancer-related mortality worldwide, with poor prognosis largely due to late-stage diagnosis. Current s...
Accurately distinguishing between primary and gastrointestinal metastatic mucinous ovarian carcinoma (MOC) is crucial but remains highly challenging. ...
OBJECTIVE: This study aims to bridge toxicological target prediction and bladder cancer transcriptomics by systematically identifying molecular signat...
BACKGROUND: Despite advances in whole-genome sequencing and identifying cancer-associated genetic alterations, understanding the influence of multiple...
Cancer therapies such as chemotherapy, radiopharmaceutical therapy, and transarterial embolization rely on effective drug or radiation delivery throug...
Increasing evidence suggests that Graves' disease (GD) may increase the risk of thyroid cancer (THCA), but diagnostic biomarkers associated with it re...
Small cell lung cancer (SCLC) is known for its rapid growth and early metastasis, and SCLC patients are highly susceptible to chemoresistance. Studies...
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide, with approximately 25-30 % of cases exhibiting a familial compo...
In metastatic melanoma with a BRAFV600 mutation, inhibitors of BRAF and MEK have improved survival. Resistance may be acquired through late genetic al...
AIMS AND OBJECTIVES: In the present paper, we compared the efficiency of six transfer learning models to detect malignant cells in urine cytology. We ...
Small-cell lung cancer (SCLC) is frequently subdivided into four molecular subtypes according to the activity of key transcription factors (TFs) NEURO...
Colorectal cancer (CRC) remains a major global health burden with the gut microbiome emerging as a critical contributor to tumor initiation and progre...
INTRODUCTION: Artificial intelligence (AI) can complete tasks that once required human cognitive effort. As a result, assessments that traditionally m...
We investigated the carcinogenic effects of four endocrine-disrupting chemicals-bisphenol A (BPA), diethyl phthalate (DEP), dimethyl phthalate (DMP), ...
BACKGROUND: Valid stratification factors for patients with epithelial ovarian cancer are still lacking and individualisation of care remains an unmet ...
BACKGROUND: Current molecular classification model for thyroid cancer (TC), which relies on BRAF-RAS score genes has limited efficacy in differentiati...
Systemic Epstein-Barr virus-positive (EBV-positive) T/NK cell lymphoproliferative diseases of childhood (sEBV+T/NK-LPD) are a spectrum of rare disease...
BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality globally, with over 905,700 new cases and 830,200 de...